Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:21:10.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of a clinical investigation involving FT500 as monotherapy and in combination with immune checkpoint inhibitors for participants with advanced solid tumors.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:31.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying health conditions and prior treatments required for inclusion in the study. Previously, this section had no information provided.
    Difference
    47%
    Check dated 2024-05-22T21:03:16.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:25:04.000Z thumbnail image

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.